References
- European Parliament and Council ( 2007 ). Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 . Official Journal of the European Union 10.12.2007. L324/121–137 . http://ec.europa.eu/health/files/eudralex/vol-1/reg_2007_1394/reg_2007_1394_en.pdf
- Mason C , BrindleyDA , Culme-SeymourEJ , DavieNL . Cell therapy industry: billion dollar global business with unlimited potential . Regen. Med.6 ( 3 ), 265 – 272 ( 2011 ).
- Freeman DW . Dendreon’s $93,000 prostate cancer drug: is Provenge worth it?CBS News. 31 March ( 2011 ). www.cbsnews.com/news/dendreons-93000-prostate-cancer-drug-is-provenge-worth-it
- Hirschler B . Analysis: Entering the age of the $1 million medicine . Reuters. 3 January ( 2013 ). www.reuters.com/article/2013/01/03/us-rarediseases-idUSBRE9020C120130103
- House of Lords Science and Technology Committee . Regenerative Medicine Report. 1st Report of Session 2013–2014 . House of Lords, London, UK ( July 2013 ). www.publications.parliament.uk/pa/ld201314/ldselect/ldsctech/23/23.pdf
- National Institute for Health and Care Excellence . NICE seeks views on how it assesses drugs and other technologies for the NHS . 27 March ( 2014 ). www.nice.org.uk/News/Press-and-Media/nice-seeks-views-on-how-it-assesses-drugs-and-other-technologies-for-the-nhs
- Department of Health . The Pharmaceutical Price Regulation Scheme 2014 . Department of Health, London, UK ( December 2013 ). www.gov.uk/government/uploads/system/uploads/attachment_data/file/282523/Pharmaceutical_Price_Regulation.pdf
- Benoff M , BergK , BlansettLet al. Pricing & Market Access Outlook 2013 Edition . IMS Consulting Group ( 2013 ). www.imsconsultinggroup.com/deployedfiles/consulting/Global/Content/Our%20Latest%20Thinking/Static%20Files/pma_outlook_2013.pdf
- Office of Fair Trading . The Pharmaceutical Price Regulation Scheme: an OFT market study . Office of Fair Trading , London, UK ( February 2007 ). www.oft.gov.uk/shared_oft/reports/comp_policy/oft885.pdf
- Leopold C , VoglerS , Mantel-TeeuwisseAK , de JoncheereK , LeufkensHGM , LaingR . Differences in external price referencing in Europe – a descriptive overview . Health Policy104 ( 1 ), 50 – 60 ( 2012 ).
- EuroScan International Network . http://euroscan.org.uk
- Simpson S . Regenerative medicine – on the horizon?EuroScan Newsletter ( June 2013 ). http://euroscan.org.uk/mmlib/includes/sendfile.php?id=147
- Kaiser Family Foundation . Snapshots: Health Care Spending in the United States & Selected OECD Countries . April 12 ( 2011 ). http://kff.org/health-costs/issue-brief/snapshots-health-care-spending-in-the-united-states-selected-oecd-countries
- Harker R . NHS funding and expenditure . House of Commons, London, UK ( April 2012 ). www.nhshistory.net/parlymoney.pdf
- Paris V , BelloniA . Value in Pharmaceutical Pricing . OECD Health Working Papers No. 63.OECD Publishing , Paris, France ( 2013 ). 10.1787/5k43jc9v6knx-en
- Sorenson C , DrummondM , KanavosP . Observatory on Health Systems and Policies . In: Ensuring Value For Money in Healthcare. The Role of Health Technology Assessment in the European Union ( 2008 ). MPG Books Ltd , Cornwall, UK . www.ispor.org/congresses/prague1110/documents/PlenaryII-Role-of-HTA-in-the-EU.pdf
- Espín J , RoviraJ , GarcíaL . Experiences and Impact of European Risk-Sharing Schemes Focusing on Oncology Medicines . EMINET/European Commission (January 2011) . http://whocc.goeg.at/Literaturliste/Dokumente/FurtherReading/Experiences%20and%20impact%20of%20European%20risk-sharing%20schemes.pdf
- National Institute for Health and Care Excellence . NICE technology appraisal guidance . www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-technology-appraisal-guidance
- National Institute for Health and Care Excellence . NICE highly specialised technologies guidance . www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-highly-specialised-technologies-guidance
- NHS England . Specialised services . www.england.nhs.uk/ourwork/commissioning/spec-services